# Prevention of Hemorrhage After Implantation of Mechanical Circulatory Support

> **NCT02488525** · PHASE3 · TERMINATED · sponsor: **University Hospital, Lille** · enrollment: 31 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Prophylactic treatment with Wilfactin

## Key facts

- **NCT ID:** NCT02488525
- **Lead sponsor:** University Hospital, Lille
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-01-20
- **Primary completion:** 2018-09-05
- **Final completion:** 2018-09-05
- **Target enrollment:** 31 (ACTUAL)
- **Why stopped:** deficient inclusion
- **Last updated:** 2019-07-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02488525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02488525, "Prevention of Hemorrhage After Implantation of Mechanical Circulatory Support". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02488525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*